Page last updated: 2024-08-16

salmeterol xinafoate and Bone Fractures

salmeterol xinafoate has been researched along with Bone Fractures in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, JA; Calverley, PMA; Celli, B; Ferguson, GT; Jenkins, CR; Jones, PW; Vestbo, J; Willits, LR; Yates, JC1
Davis, KJ; Miller, DP; Sampson, T; Watkins, SE1

Trials

1 trial(s) available for salmeterol xinafoate and Bone Fractures

ArticleYear
Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.
    Chest, 2009, Volume: 136, Issue:6

    Topics: Aged; Albuterol; Androstadienes; Bone Density; Bone Diseases, Metabolic; Bronchodilator Agents; Disease Progression; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis; Prevalence; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; Salmeterol Xinafoate; Treatment Outcome; United States

2009

Other Studies

1 other study(ies) available for salmeterol xinafoate and Bone Fractures

ArticleYear
Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of nonvertebral fractures among patients with COPD in the UK General Practice Research Database.
    The Physician and sportsmedicine, 2010, Volume: 38, Issue:4

    Topics: Administration, Inhalation; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Inflammatory Agents; Bronchodilator Agents; Case-Control Studies; Comorbidity; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluticasone; Fractures, Bone; Humans; Incidence; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Risk Factors; Salmeterol Xinafoate; United Kingdom

2010